U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199192) titled 'Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial' on Sept. 17.
Brief Summary: Multicenter, parallel-group, randomized clinical trial comparing the administration of systemic corticosteroids at a dose equivalent to 40 mg of prednisolone per day for 7 days vs no corticosteroid administration among adults hospitalized with severe acute respiratory infection and hypoxemia.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Hypoxemia
Severe Acute Respiratory Syndrome
Intervention:
DRUG: Corticosteroid
systemic corticosteroids at a dose equivalent to 40 mg of prednisolone per day for 7 days or until...